Revision of the ARRIVE guidelines: rationale and scope

BMJ Open Science · Published 2018-06-01 · DOI 10.1136/bmjos-2018-000002

Authors being retrieved — see the publisher record. https://doi.org/10.1136/bmjos-2018-000002

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2018

Related articles

• Crocodylus porosus: a potential source of anticancer moleculesCrocodylusporosus: a potential source of anticancer molecules · BMJ Open Science · 2020 · Same journal
• What is the optimum design for my animal experiment? · BMJ Open Science · 2021 · Same journal
• Effects of cannabinoids in Parkinson’s disease animal models: a systematic review and meta-analysis · BMJ Open Science · 2022 · Same journal
• How a few poorly designed COVID-19 studies may have contributed to misinformation in Brazil: the case for evidence-based communication of science · BMJ Open Science · 2021 · Same journal
• Road to FAIR genomes: a gap analysis of NGS data generation and sharing in the Netherlands · BMJ Open Science · 2022 · Same journal
• Technological advances in preclinical meta-research · BMJ Open Science · 2021 · Same journal
• Inaugural editorial: advancing preclinical and translational research ofrelevance to medicineInaugural editorial: advancing preclinical andtranslational research of relevance to medicine · BMJ Open Science · 2017 · Same journal
• Comparison of commonly used methods in random effects meta-analysis: application to preclinical data in drug discovery research · BMJ Open Science · 2021 · Same journal
• Publication rate in preclinical research: a plea forpreregistrationPublication rate in preclinical research: a plea forpreregistration · BMJ Open Science · 2020 · Same journal
• Administration of galacto-oligosaccharide prebiotics in the Flinders Sensitive Line animal model of depression · BMJ Open Science · 2019 · Same journal